ZA200608843B - Antimycobacterial pharmaceutical composition comprising an antitubercular drug - Google Patents

Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Info

Publication number
ZA200608843B
ZA200608843B ZA200608843A ZA200608843A ZA200608843B ZA 200608843 B ZA200608843 B ZA 200608843B ZA 200608843 A ZA200608843 A ZA 200608843A ZA 200608843 A ZA200608843 A ZA 200608843A ZA 200608843 B ZA200608843 B ZA 200608843B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
antitubercular drug
antimycobacterial pharmaceutical
antimycobacterial
antitubercular
Prior art date
Application number
ZA200608843A
Other languages
English (en)
Inventor
Arora Sudershan Kumar
Sinha Rakesh
Sinha Noelima
Upadhyaya Ram Shankar
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of ZA200608843B publication Critical patent/ZA200608843B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200608843A 2004-05-12 2006-10-24 Antimycobacterial pharmaceutical composition comprising an antitubercular drug ZA200608843B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/844,992 US7491721B2 (en) 2004-05-12 2004-05-12 Antimycobacterial pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA200608843B true ZA200608843B (en) 2008-07-30

Family

ID=34960626

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200608843A ZA200608843B (en) 2004-05-12 2006-10-24 Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Country Status (44)

Country Link
US (1) US7491721B2 (fr)
EP (1) EP1750765B1 (fr)
JP (1) JP2007537242A (fr)
KR (1) KR100854309B1 (fr)
CN (1) CN1956732B (fr)
AP (1) AP1994A (fr)
AR (1) AR048948A1 (fr)
AT (1) ATE373488T1 (fr)
AU (1) AU2004319259A1 (fr)
BR (1) BRPI0418770A (fr)
CA (1) CA2566440C (fr)
CR (1) CR8748A (fr)
DE (1) DE602004009113T2 (fr)
DK (1) DK1750765T3 (fr)
DO (1) DOP2005000085A (fr)
EA (1) EA009694B1 (fr)
EC (1) ECSP066965A (fr)
ES (1) ES2294577T3 (fr)
GE (1) GEP20094805B (fr)
HN (1) HN2005000210A (fr)
HR (1) HRP20070574T3 (fr)
IL (1) IL178858A (fr)
IS (1) IS8559A (fr)
JO (1) JO2471B1 (fr)
MA (1) MA28603B1 (fr)
MX (1) MXPA06012984A (fr)
MY (1) MY139187A (fr)
NI (1) NI200600270A (fr)
NO (1) NO20065725L (fr)
NZ (1) NZ550892A (fr)
PA (1) PA8633001A1 (fr)
PE (1) PE20060353A1 (fr)
PL (1) PL1750765T3 (fr)
PT (1) PT1750765E (fr)
RS (1) RS20060624A (fr)
SA (1) SA05260130B1 (fr)
SI (1) SI1750765T1 (fr)
SM (1) SM200500011B (fr)
SV (1) SV2006002109A (fr)
TN (1) TNSN06349A1 (fr)
UA (1) UA82782C2 (fr)
UY (1) UY28893A1 (fr)
WO (1) WO2005107809A2 (fr)
ZA (1) ZA200608843B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118509A1 (en) * 2005-04-11 2009-05-07 Lupin Limited Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) * 2008-10-02 2013-11-13 公益財団法人微生物化学研究会 抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) * 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
AU2010292148A1 (en) * 2009-09-11 2012-04-12 Vertex Pharmaceuticals Incorporated Compositions of N-benzyl-3-(4-chlorophenyl)-2- [methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-N- [3-(4-pyridyl)-1-[2-[4-pyridyl)ethy]propyl]propanamide and uses thereof
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
WO2023217239A1 (fr) * 2022-05-12 2023-11-16 广州嘉越医药科技有限公司 Composition pharmaceutique et utilisation associée
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same
CN118743705B (zh) * 2024-08-12 2024-11-15 深圳大学 药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
BR0215873A (pt) * 2002-09-20 2005-07-12 Lupin Ltd Composto, composição farmacêutica, método de inibição de desenvolvimento de células microbianas, método para o tratamento de condições microbianas em mamìferos e processo para a preparação de um composto

Also Published As

Publication number Publication date
SI1750765T1 (sl) 2008-04-30
AU2004319259A1 (en) 2005-11-17
US7491721B2 (en) 2009-02-17
CR8748A (es) 2008-06-02
NO20065725L (no) 2006-12-12
PT1750765E (pt) 2007-12-31
CN1956732B (zh) 2010-04-28
MA28603B1 (fr) 2007-05-02
MXPA06012984A (es) 2007-04-23
SV2006002109A (es) 2006-04-18
DOP2005000085A (es) 2007-01-15
AR048948A1 (es) 2006-06-14
HK1098962A1 (en) 2007-08-03
KR20070007920A (ko) 2007-01-16
DK1750765T3 (da) 2008-01-28
CA2566440A1 (fr) 2005-11-17
WO2005107809A3 (fr) 2006-01-26
RS20060624A (sr) 2008-09-29
NI200600270A (es) 2007-12-11
ATE373488T1 (de) 2007-10-15
UY28893A1 (es) 2005-12-30
AP1994A (en) 2009-04-09
BRPI0418770A (pt) 2007-10-09
SM200500011A (it) 2005-11-16
KR100854309B1 (ko) 2008-08-26
TNSN06349A1 (en) 2008-02-22
MY139187A (en) 2009-08-28
US20050256128A1 (en) 2005-11-17
IL178858A (en) 2010-06-16
IS8559A (is) 2006-10-26
SM200500011B (it) 2005-11-16
SA05260130B1 (ar) 2008-05-04
JO2471B1 (en) 2009-01-20
JP2007537242A (ja) 2007-12-20
DE602004009113T2 (de) 2008-06-19
ECSP066965A (es) 2006-12-20
GEP20094805B (en) 2009-10-26
EP1750765B1 (fr) 2007-09-19
HRP20070574T3 (en) 2008-01-31
IL178858A0 (en) 2007-03-08
NZ550892A (en) 2009-12-24
AP2006003807A0 (en) 2006-12-31
ES2294577T3 (es) 2008-04-01
WO2005107809A2 (fr) 2005-11-17
EP1750765A2 (fr) 2007-02-14
PE20060353A1 (es) 2006-07-08
CN1956732A (zh) 2007-05-02
HN2005000210A (es) 2009-03-17
PL1750765T3 (pl) 2008-02-29
UA82782C2 (uk) 2008-05-12
DE602004009113D1 (de) 2007-10-31
CA2566440C (fr) 2009-08-04
EA200601952A1 (ru) 2007-02-27
WO2005107809A8 (fr) 2006-05-18
EA009694B1 (ru) 2008-02-28
PA8633001A1 (es) 2006-12-07

Similar Documents

Publication Publication Date Title
TWI367096B (en) Vitamin-receptor binding drug delivery conjugates and pharmaceutical compositions
IL185390A (en) A solid dosage form
IL177566A0 (en) Pharmaceutical formulations
IL190292A (en) History of pyridopyrimidinone and their pharmaceutical preparations
IL179207A0 (en) Pyrrole derivatives and pharmaceutical compositions containing the same
IL221323A0 (en) 1-methyl-1h- pyridin-2-one- phenanthridine derivatives and pharmaceutical compositions containing the same
EP1898922A4 (fr) Medicament ou composes pharmaceutiques ameliores et preparation associee
IL189781A0 (en) Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
GB0426301D0 (en) Pharmaceutical formulations
IL177168A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL188744A0 (en) High drug load formulations and dosage forms
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
IL183986A0 (en) Pharmaceutical compounds and compositions
PL1957073T3 (pl) Substancja lecznicza
IL181730A0 (en) Benzodiazinone derivatives and pharmaceutical compositions containing the same
IL178858A0 (en) An antimycobacterial pharmaceutical composition comprising an antitubercular drug
IL177499A0 (en) Thio-containing hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
GB0416397D0 (en) Pharmaceutical formulations
IL178067A0 (en) Pharmaceutical dosage forms and compositions
GB0423800D0 (en) New pharmaceutical formulations
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne
IL177498A0 (en) Difluoroethoxy -substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
IL177497A0 (en) Isoamido-substituted hydroxy-6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same
IL179669A0 (en) Benzoimidazole derivatives and pharmaceutical compositions containing the same
GB0406048D0 (en) Drug formulations